May be generalized or localized to a specific body part
14-24% may have an underlying systemic disease
Differential Diagnosis and Evaluation (Yosipovitch)
Note:
Pruritus of Undetermined Origin (PUO) is defined as pruritus >3 weeks of undetermined origin (ultimately remains idiopathic in 70-80% with PUO)
Periodic re-evaluation is warranted if no cause is identified
The presence of a rash does not necessarily indicate a primary skin disease; lichenification, prurigo nodules, patches of dermatitis, and excoriations can result from rubbing and scratching
"Wheal-less urticaria" is thought to occur when histamine and other released mediators are sufficient to trigger a sensory response but not vascular effects (reported in case of aquagenic pruritus, contact urticaria, dermatographic urticaria, cholinergic urticaria)
Polycythemia vera - ~50% have severe, prickly, distressing discomfort within minutes of water contact ("bath itch") which lasts 15-60 min, may precede overt disease onset by several years, and may be associated with elevated serum/urinary histamine levels but antihistamines are generally ineffective
Hodgkin's disease - 30% have pruritus whch may be an early or presenting symptom, worse on lower body, burning and more intense at night, and the itch may correlate with disease severity
Brachioradial pruritus - sunlight-induced chronic episodic pruritus localized to outer aspect of elbow and adjacent lower and upper arms, more common in fair-skinned people in tropical climates; treatments include sun protection, topical camphor or menthol, cervical spine manipulation, capsaicin, topical anesthetics
Treatment (Yosipovitch)
Example approach for chronic idiopathic pruritus:
Start with frequent moisturization, mild cleansers, topical antipruritic agents (e.g. pramoxine), avoidance of trigger factors (e.g. heat due to excessive bedding)
First line systemic therapy is often sedating antihistamines, but efficacy is limited
Second line systemic therapy may be gabapentin, starting at 300 mg/day and progressing up to 2400 mg/day in divided doses, with mirtazapine (7.5-15 mg) added at night if still symptomatic)
Background
Differential Diagnosis and Evaluation (Yosipovitch)
Note:
Treatment (Yosipovitch)
References